Get the latest tech news
Cleerly raises $106M from Insight Partners for AI heart health early detection
Although heart disease is the leading cause of death in the United States, a significant portion of people who experience heart attacks are unaware that
By analyzing CT scans of the heart, the company’s AI software aims to identify early stage coronary artery disease, similar to how mammograms and colonoscopies detect breast and colon cancer. Cleerly is currently running a large, multi-year clinical trial to prove that its screen can catch heart conditions in people without disease symptoms more accurately than other routine non-invasive methods such as measuring blood pressure and cholesterol levels. Min told TechCrunch that while the company did not necessarily need additional capital, given that Cleerly’s other backers were healthcare VCs or crossover firms, it was excited to add Insight Partners, one of the largest enterprise software investors, to its cap table.
Or read this on TechCrunch
